Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age
There is some evidence to support the effectiveness of preventative zinc supplementation particularly, where the risk of zinc deficiency is high. However, more evidence on optimal intervention characteristics such as supplement dose is needed.
Zinc deficiency is responsible for significant morbidity and mortality rates associated with diarrhoea, malaria and pneumonia in children aged six months to 12 years. The aim of the review was to assess the effects of zinc supplementation for preventing mortality and morbidity, and for promoting growth, in children aged six months to 12 years of age.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.